2018
DOI: 10.1080/13813455.2018.1510968
|View full text |Cite
|
Sign up to set email alerts
|

High-intensity interval training (HIIT) alleviated NAFLD feature via miR-122 induction in liver of high-fat high-fructose diet induced diabetic rats

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
24
1

Year Published

2019
2019
2024
2024

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 31 publications
(26 citation statements)
references
References 61 publications
1
24
1
Order By: Relevance
“…Similarly, Kalaki‐Jouybari et al 180 also reported a diabetic rat model in Wistar rats after supplementation with HFHSD (30% fat and 20% fructose) for 5 months. These authors confirmed the presence of T2DM features, such as hyperglycaemia (FBG > 200 mg/dl), insulin resistance (elevated HOMA‐IR), dyslipidaemia and hepatic steatosis 180 . However, both studies confirmed the diabetic phenotype in animals displaying FBG > 126 mg/dl, without discriminating between the time period of fasting.…”
Section: Diet‐induced Rodent Modelsmentioning
confidence: 87%
See 1 more Smart Citation
“…Similarly, Kalaki‐Jouybari et al 180 also reported a diabetic rat model in Wistar rats after supplementation with HFHSD (30% fat and 20% fructose) for 5 months. These authors confirmed the presence of T2DM features, such as hyperglycaemia (FBG > 200 mg/dl), insulin resistance (elevated HOMA‐IR), dyslipidaemia and hepatic steatosis 180 . However, both studies confirmed the diabetic phenotype in animals displaying FBG > 126 mg/dl, without discriminating between the time period of fasting.…”
Section: Diet‐induced Rodent Modelsmentioning
confidence: 87%
“…Upon dietary supplementation of fructose (25% in drinking water) within an HFD regimen of 4 months, Wistar rats displayed T2DM features comprising systemic hyperglycaemia (FBG > 126 mg/dl), insulin resistance (HOMA‐IR > 2.4), glucose intolerance, dyslipidaemia, oxidative stress associated with endothelial dysfunction and hepatic steatosis 159 . Similarly, Kalaki‐Jouybari et al 180 also reported a diabetic rat model in Wistar rats after supplementation with HFHSD (30% fat and 20% fructose) for 5 months. These authors confirmed the presence of T2DM features, such as hyperglycaemia (FBG > 200 mg/dl), insulin resistance (elevated HOMA‐IR), dyslipidaemia and hepatic steatosis 180 .…”
Section: Diet‐induced Rodent Modelsmentioning
confidence: 96%
“…32 Further, HIIT training reduced NAFLDrelated features by targeting miR122 induction in the liver of high-fat, high-fructose diet-induced diabetic rats. 15 Also, Khakdan et al demonstrated that HIIT intervention effectively improved heart function in an miR195 dependent manner and alleviated high-fat, high-fructose diet-induced cardiomyopathy in diabetic rats. 13 The main finding of this study was that the HFD considerably increased M1 markers and exercise interventions reversed them.…”
Section: Discussionmentioning
confidence: 99%
“…The results demonstrated that exercise intervention, especially HIIT, efficiently alleviated antidiabetic and hypolipidemic markers. 13,15 Recent evidence indicates that HIIT can improve insulin sensitivity and metabolic syndrome; however, the molecular mechanism of HIIT effects has not yet been well-defined. 16 Adipose-tissue inflammation is essential among several molecular mechanisms of the beneficial effects of training.…”
Section: Introductionmentioning
confidence: 99%
“…The findings of animal studies [24,25,26,27,28] are highly suggestive of the physiological mechanism of the favorable impact of HIIT on NAFLD. Previous studies have shown that improved hepatic steatosis using HIIT is associated with increased hepatic mitochondrial function (citrate synthase activity and fatty acid oxidation), increased hepatic peroxisome proliferator-activated receptor (PPAR)-α content [24], increased hepatic PPAR-γ and glutathione peroxidase 4 gene expression [25], improved hepatic and adipose tissue insulin sensitivity independent of AMP-activated protein kinase phosphorylation of acetyl-CoA carboxylase [26], increased hepatic miR-122 expression [27], activated hepatic AMP-mediated protein kinase (AMPK) with upregulated adiponectin receptor 2 signaling pathway and downregulated NF-κB signaling pathway [28], and reduced hepatic M1 macrophage polarization markers [24], which suppress de novo hepatic lipogenesis [24,28]. AMPK-mediated improvement in mitochondrial function seems to play a key role in the treatment of NAFLD.…”
Section: Possible Physiological Mechanismsmentioning
confidence: 99%